 WEST LAFAYETTE, Ind., July 15, 2021 GLOBE NEWSWIRE -- Inotiv, Inc. NASDAQ: NOTV the Company, We, Our or Inotiv, a leading contract research organization specializing in nonclinical and bioanalytical drug discovery and development services, today announced that the Company has purchased the physical assets of a Tennessee-based laboratory services provider that ceased operations. The assets, which include lab instrumentation, stock consumables and chemicals, lab benchwork, and office furniture, were acquired for approximately 1.3 million, a substantial discount to the Companys estimate of fair market value. 